FDA
approval
·
FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies
Summary
FDA issued an Emergency Use Authorization for Simparica TRIO to treat New World screwworm infestations in dogs and puppies.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (sarolaner, moxidectin, and pyrantel chewable tablets) for the treatment of New World screwworm (NWS) infestations (myiasis) in dogs and puppies.